Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc announced that on February 27, 2026, it purchased 192,500 ordinary shares at a volume-weighted average price of 1,346.66 pence per share as part of its $250 million share repurchase program. The company intends to cancel these shares, and following this transaction, it holds 12,833,233 shares in treasury, with 221,606,453 ordinary shares remaining in issue.

Disclaimer*

UK 100

Latest directors dealings